TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
QIAGEN DNA Synthesis AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
101,384
|
74,216
|
83,427 |
Financial expenses |
9,058
|
4,693
|
2,374 |
Earnings before taxes |
-40,125
|
-50,323
|
-31,694 |
EBITDA |
-20,073
|
-38,047
|
-22,239 |
Total assets |
170,759
|
150,901
|
138,879 |
Current assets |
87,680
|
84,987
|
72,223 |
Current liabilities |
133,414
|
132,953
|
127,007 |
Equity capital |
37,344
|
17,948
|
11,872 |
- share capital |
203
|
189
|
195 |
Employees (average) |
99
|
105
|
97 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
21.9%
|
11.9%
|
8.5% |
Turnover per employee |
1,024
|
707
|
860 |
Profit as a percentage of turnover |
-39.6%
|
-67.8%
|
-38.0% |
Return on assets (ROA) |
-18.2%
|
-30.2%
|
-21.1% |
Current ratio |
65.7%
|
63.9%
|
56.9% |
Return on equity (ROE) |
-107.4%
|
-280.4%
|
-267.0% |
Change turnover |
21,902
|
-6,704
|
-43,543 |
Change turnover % |
28%
|
-8%
|
-34% |
Chg. No. of employees |
-6
|
8
|
6 |
Chg. No. of employees % |
-6%
|
8%
|
7% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.